Sign in

Kenneth Stacherski

Chief Global Supply Chain and Service Officer at GEHC
Executive

About Kenneth Stacherski

Kenneth R. Stacherski is GE HealthCare’s Chief Global Supply Chain and Service Officer, serving in this role since the Spin-Off; in 2025 SEC filings he is identified as Chief Enterprise Operating Officer, indicating an expanded enterprise operations remit . He is 54 years old and is part of the company’s executive officer cohort disclosed in the 2024 Form 10-K . Company performance context during his tenure: 2024 revenues were $19.7 billion (+1% YoY); net income was $2.0 billion; Adjusted EBIT was $3.2 billion; diluted EPS was $4.34; cash from operations was $2.0 billion and free cash flow was $1.6 billion . Education is not disclosed in the referenced filings.

Past Roles

OrganizationRoleYearsStrategic Impact
GE HealthCare (pre-Spin-Off)Chief Global Supply Chain and Service OfficerOct 2022–Spin-OffLed global integrated supply chain and service across GE’s healthcare business ahead of and through the Spin-Off .
Array TechnologiesChief Operations OfficerJul 2021–Oct 2022Led global integrated supply chain strategy for solar tracking company, driving end-to-end supply optimization .
HoneywellVP Integrated Supply Chain; VP Enterprise Digital Transformation; VP Portfolio Transformation; VP & GM Honeywell UOP; VP Procurement, Logistics & Trade Compliance; Global Director Integrated Supply ChainJun 2011–Jun 2021 (roles with dated tenures: 2013–2021)Progressive operations, transformation, and general management roles across supply chain, digital, portfolio, and procurement/logistics .
Composite Technologies CorporationPresident & Chief Operating OfficerPrior to Honeywell (dates not specified)Led operations at composite materials firm (details not further disclosed) .
Ford Motor CompanyOperations roles13 yearsAutomotive operations experience foundational to later supply chain leadership .

External Roles

No external public company directorships or committee roles are mentioned for Stacherski in GE HealthCare’s executive biographies within the 2024 Form 10-K or 2025 Proxy .

Fixed Compensation

Not disclosed for Stacherski in GE HealthCare’s proxy (he is not listed as a Named Executive Officer). Company-wide policies include stock ownership requirements and governance practices summarized below (see Employment Terms) .

Performance Compensation (Equity Awards and Vesting)

Award DateInstrumentShares/UnitsStrike PriceVesting ScheduleExpirationNotes
02/01/2023RSUNot explicitly stated in filing text; time-basedN/A50% on 02/01/2025; 50% on 02/01/2026N/ARSU vests in two tranches; each RSU settles into one GEHC share .
02/01/2023Employee Stock Option23,515$70.0150% exercisable on 02/01/2025; 50% exercisable on 02/01/202602/01/2033Time-based vesting; options confer right to buy GEHC common stock .
08/15/2025RSU10,217N/A50% on 08/15/2027; 50% on 08/15/2028N/ATwo-year cliff vesting schedule over 2027 and 2028; standard time-based RSU .

No PSUs (performance share units), performance weightings, or payout curves are disclosed for Stacherski in the available filings; awards above are time-based RSUs and options with stated vesting schedules .

Equity Ownership & Alignment

DateEventShares Disposed (Tax Withholding)Beneficial Ownership AfterNotes
08/15/2025RSU grantN/A41,888Beneficial ownership reported post-grant in Form 4 summary .
09/01/2025RSU vest – tax withholding45841,430Code F (disposition to cover taxes); routine withholding on RSU vest .
09/01/2025RSU vest – tax withholding43440,996Second withholding entry same date; routine administrative transaction .
  • Stock ownership guidelines: CEO 6x base salary; other Executives 3x base salary; until compliant, must retain at least 75% of net shares from RSU/PSU vesting or option exercise .
  • No hedging or pledging permitted for directors, executive officers, and employees per Securities Trading Policy and proxy .

Employment Terms

  • Severance and change-of-control: Under the Executive Severance Plan, Leadership Team members (other than CEO) receive 24 months of base salary plus 2x target annual bonus upon qualifying termination within 24 months post-change in control; benefits continuation and outplacement for 24 months; equity treated per plan agreements; no single-trigger cash severance or automatic equity acceleration unless awards are not assumed/continued in the transaction .
  • Clawback: Robust clawback policy authorizes recoupment of time- and performance-based awards in cases of misconduct beyond financial restatements; annual compensation risk assessment conducted by independent consultant; no hedging or pledging; equity grant practices avoid grants around MNPI .
  • Insider trading and retention: Executives subject to 3x salary ownership guideline with 75% net-share retention until met; Insider Trading Policy filed as Exhibit 19.1 to the 2024 Form 10-K .
  • Non-compete/non-solicit: Payment of severance benefits requires execution of release including, where legally permissible, non-competition, non-solicitation, and non-disparagement obligations .

Investment Implications

  • Alignment: Multi-year, time-based RSUs (2025 grant vesting in 2027–2028) and option awards (2023 grant with 2033 expiry) build meaningful retention and long-dated equity exposure; strict no-hedging/pledging and 3x salary ownership guideline reinforce alignment and reduce agency risk .
  • Selling pressure: Observed Form 4 “F” code dispositions relate to tax withholding at vest and do not reflect open-market sales, suggesting limited direct selling pressure from the executive; upcoming vest dates (Aug 2027/2028) are identifiable for monitoring flows .
  • Retention risk: The two-tranche RSU vesting and option overhang to 2033 imply low near-term departure incentives; severance economics (2x bonus, 24 months salary) are competitive but not excessive and are double-trigger in change-of-control contexts, moderating perverse incentives .
  • Execution leverage: Stacherski’s deep supply chain and operations background across Honeywell, automotive, and energy-adjacent sectors is directly tied to GEHC’s Business Optimization pillar and cash generation priorities; 2024 results indicate steady top-line and adjusted profitability that support a pay-for-performance framework at the company level .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%